Sign in

CIK 0001802768 · Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
(212) 883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
  1. 4 Grant or award Director acquired 4,545 shares (grant or award)
  2. 4 Grant or award Director acquired 4,545 shares (grant or award)
  3. 4 Grant or award Director acquired 4,545 shares (grant or award)
  4. 4 Grant or award Director acquired 4,545 shares (grant or award)
  5. 4 Grant or award Director acquired 4,545 shares (grant or award)
  6. 4 Grant or award Director acquired 4,545 shares (grant or award)
  7. 4 Grant or award Director acquired 4,545 shares (grant or award)
  8. 4 Planned sale EVP & CFO sold 64,399 shares at $53.98 ($3,476,116)
  9. 4 Planned sale EVP, Research & Investments sold 13,684 shares at $52.75 ($721,838)
  10. 4 Planned sale EVP, Research & Investments sold 13,684 shares at $53.06 ($726,137)
  11. 4 Planned sale Director sold 3,045 shares at $53.00 ($161,385)
  12. 4 Grant or award CEO, Chairman of the Board acquired 143,821 shares (grant or award)
  13. 4 Grant or award EVP & CFO acquired 24,263 shares (grant or award)
  14. 4 Grant or award EVP & Vice Chairman acquired 24,263 shares (grant or award)
  15. 4 Grant or award EVP, Research & Investments acquired 18,197 shares (grant or award)
  16. 4 Planned sale EVP & CFO sold 34,791 shares at $49.78 ($1,731,840)
  17. 4 Planned sale EVP & CFO sold 34,791 shares at $48.33 ($1,681,512)
  18. 4 Grant or award Director acquired 815 shares (grant or award)
  19. 4 Planned sale EVP & CFO sold 34,791 shares at $45.53 ($1,583,989)
  20. 4 Planned sale EVP & CFO sold 34,791 shares at an average $46.78 ($1,627,534)

Page 2 of 18 · 342 filings